Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Operating Leases (2021 - 2023)

Rapid Therapeutic Science Laboratories' Operating Leases history spans 3 years, with the latest figure at $338542.0 for Q2 2023.

  • For Q2 2023, Operating Leases changed 0.0% year-over-year to $338542.0; the TTM value through Jun 2023 reached $338542.0, changed 0.0%, while the annual FY2022 figure was $280235.0, 26.01% down from the prior year.
  • Operating Leases for Q2 2023 was $338542.0 at Rapid Therapeutic Science Laboratories, down from $358768.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $397410.0 in Q3 2022 and bottomed at $280235.0 in Q4 2022.
  • The 3-year median for Operating Leases is $358768.0 (2022), against an average of $350144.1.
  • The largest annual shift saw Operating Leases decreased 26.01% in 2022 before it changed 0.0% in 2023.
  • A 3-year view of Operating Leases shows it stood at $378744.0 in 2021, then fell by 26.01% to $280235.0 in 2022, then grew by 20.81% to $338542.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Operating Leases are $338542.0 (Q2 2023), $358768.0 (Q1 2023), and $280235.0 (Q4 2022).